Bayer said the number of deaths linked to its cholesterol drug Baycol has doubled from earlier estimate of 52.
(via LA Times)

Bayer reported a loss of $165 million for the third quarter, blaming a weak global economy and the withdrawal of Baycol after it was linked to patient deaths.
(via LA Times)

The US District Court presiding over the national Baycol Products Liability Litigation approved an early deadline to move the case to trial.
(via PR Newswire)

Bayer is pulling Baycol from Japan, just two weeks after safety fears forced it to halt sales in the rest of the world.
(via Europe CNN)

Litigation against Bayer AG over its Baycol continued to mount on Thursday with at least two new suits filed in the United States.
(via IDG)

Bayer said new reports allege 52 people died after taking the anti-cholesterol drug Baycol. Bayer pulled from the market Lipobay, which is linked to about 40 deaths, after increasing evidence that the drug caused deterioration in muscle tissue, a condition called rhabdomyolysis.
“There is currently no proof” that the drug is the cause of the deaths, […]

Bayer has discontinued the marketing and distribution of all dosage strengths of Baycol. Patients who are currently taking Baycol should have their Baycol discontinued and be switched to an alternative therapy by their physicians.
It is important to you forward any adverse event information associated with the use of Baycol to Bayer Corporation at 1-800-288-8371. You […]

FDA today announced that Bayer Pharmaceutical Division is voluntarily withdrawing Baycol (cerivastatin) from the U.S. market because of reports of sometimes fatal rhabdomyolysis, a severe muscle adverse reaction from this cholesterol-lowering (lipid-lowering) product. The FDA agrees with and supports this decision.
Baycol (cerivastatin), which was initially approved in the U.S. in 1997, is a member of […]

Bayer pulled Baycol taken by thousands of Americans from shelves Wednesday after it was associated with 31 deaths in the U.S. and at least nine deaths in other countries.
(via Europe CNN)

Recently, Bayer Corporation has voluntarily made changes to the prescribing information for Baycol in order to provide patients with more specific guidance on initiating therapy with the product.
Bayer Corporation has made these revisions because they have received reports of muscle weakness and rhabdomyolysis during the post-marketing period. A substantial number of these cases occurred in […]